Beijing Health Guard Biotechnology (BJSE:833575) ROCE % : -36.61% (As of Mar. 2024)

View and export this data going back to 2023. Start your Free Trial

What is Beijing Health Guard Biotechnology ROCE %?

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. Beijing Health Guard Biotechnology's annualized ROCE % for the quarter that ended in Mar. 2024 was -36.61%.

Beijing Health Guard Biotechnology ROCE % Historical Data

The historical data trend for Beijing Health Guard Biotechnology's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Beijing Health Guard Biotechnology ROCE % Chart

Beijing Health Guard Biotechnology Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

ROCE %

Get a 7-Day Free Trial

-59.61

-41.36

-24.90

-29.92

Beijing Health Guard Biotechnology Quarterly Data
	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
ROCE %	Get a 7-Day Free Trial															-25.15	-24.36	-30.81	-30.66	-36.61

Beijing Health Guard Biotechnology ROCE % Calculation

Beijing Health Guard Biotechnology's annualized ROCE % for the fiscal year that ended in Dec. 2023 is calculated as:

ROCE %	=	EBIT	/	( (Capital Employed	+	Capital Employed)	/ count )
		(A: Dec. 2023 )		(A: Dec. 2022 )		(A: Dec. 2023 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(A: Dec. 2023 )		(A: Dec. 2022 )		(A: Dec. 2023 )
	=	-296.98	/	( ( (1383.301 - 352.279)	+	(1454.292 - 500.317) )	/ 2 )
	=	-296.98	/	( (1031.022	+	953.975)	/ 2 )
	=	-296.98	/	992.4985
	=	-29.92 %

Beijing Health Guard Biotechnology's ROCE % of for the quarter that ended in Mar. 2024 is calculated as:

ROCE %	=	EBIT ⁽¹⁾	/	( (Capital Employed	+	Capital Employed)	/ count )
		(Q: Mar. 2024 )		(Q: Dec. 2023 )		(Q: Mar. 2024 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(Q: Mar. 2024 )		(Q: Dec. 2023 )		(Q: Mar. 2024 )
	=	-339.796	/	( ( (1454.292 - 500.317)	+	(1507.432 - 605.086) )	/ 2 )
	=	-339.796	/	( ( 953.975	+	902.346 )	/ 2 )
	=	-339.796	/	928.1605
	=	-36.61 %

(1) Note: The EBIT data used here is four times the quarterly (Mar. 2024) EBIT data.

Beijing Health Guard Biotechnology (BJSE:833575) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.

Beijing Health Guard Biotechnology ROCE % Related Terms

Thank you for viewing the detailed overview of Beijing Health Guard Biotechnology's ROCE % provided by GuruFocus.com. Please click on the following links to see related term pages.

Beijing Health Guard Biotechnology (BJSE:833575) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Beijing Health Guard Biotechnology Inc (BJSE:833575) » Definitions » ROCE %

Comparable Companies

Traded in Other Exchanges

N/A

Address

No. 7 Rongchang East Street, Beijing Economic and Technological Development Zone, Room 201 and 202, Building A2, Beijing, CHN, 100176

Website

Beijing Health Guard Biotechnology Inc engages in the research, development, and industrialization of recombinant protein vaccines. It mainly develops HPV vaccines in China and also advances multiple innovative candidate vaccines for other infectious diseases. Its core pipeline product includes a trivalent and a nonavalent HPV vaccine.

Beijing Health Guard Biotechnology (BJSE:833575) Headlines

No Headlines